Delisting riskEarnings in 3d
BRTX · NASDAQ · Biotechnology

BioRestorative Therapies

Develops autologous cell therapies and cell-secretome cosmetics for spine and metabolic applications.

$0.2001
After-hours close0.00 (0.00%)
At close$0.2001(−2.86%)
DateEstimateReportedSurprise
Nov 2026−$0.07
Sep 2026−$0.10
May 2026−$0.30−$0.19+36.7%
Mar 2026−$0.37−$0.370.0%
Nov 2025−$0.36−$0.33+8.3%
Aug 2025−$0.41−$0.30+26.8%

The latest year is open to everyone — the 40 quarters behind it read with an account.

Sign in
May 2025
Mar 2025
Nov 2024
Aug 2024
Jun 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Apr 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Nov 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 18, 2026−$0.07$650.0K
Sep 1, 2026−$0.10$600.0K
May 14, 2026−$0.30−$0.19+36.7%$312.5K$23.2K−92.6%
Mar 26, 2026−$0.37−$0.370.0%$150.0K$20.0K−86.7%
Nov 12, 2025−$0.36−$0.33+8.3%$460.0K$11.8K−97.4%
Aug 12, 2025−$0.41−$0.30+26.8%$200.0K$303.3K+51.7%

The latest year is open to everyone — the 40 quarters behind it read with an account.

Sign in
May 14, 2025
Mar 27, 2025
Nov 12, 2024
Aug 13, 2024
Jun 11, 2024
Mar 29, 2024
Nov 13, 2023
Aug 11, 2023
May 12, 2023
Mar 24, 2023
Nov 14, 2022
Aug 15, 2022
May 16, 2022
Mar 30, 2022
Nov 15, 2021
Aug 16, 2021
May 17, 2021
Mar 29, 2021
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Nov 13, 2019
Aug 14, 2019
May 14, 2019
Mar 29, 2019
Nov 13, 2018
Aug 14, 2018
May 15, 2018
Apr 2, 2018
Nov 14, 2017
Aug 14, 2017
May 15, 2017
Mar 21, 2017
Nov 15, 2016
Aug 15, 2016
May 13, 2016
Mar 30, 2016
Nov 23, 2015
Aug 14, 2015